MHA Comments on Medicaid Proposal to Cover LARCs in Inpatient Setting

Posted on June 18, 2018

The MHA recently submitted comments to the Medical Services Administration (MSA) in support of its proposed policy that would provide a separate Medicaid payment for long-acting reversible contraception (LARC) devices when they are provided in the inpatient hospital setting.

The current inpatient all-patient-refined diagnosis-related group (DRG) payment for deliveries was determined without the LARC device cost. Currently, Medicaid provides payment for LARCs only when these devices are provided in an outpatient setting. As the result of advocacy efforts by the MHA and hospitals, the MSA proposes to provide a separate payment to hospitals when these services are provided in the inpatient setting, effective Oct. 1, 2018.

The proposed new payment would be in addition to the inpatient DRG payment that Medicaid pays the hospital for the obstetrical services. The payment would range from $723 to $910, depending upon the specific device. The MHA supports this change and believes that increased access to these services could reduce the number of unplanned pregnancies. The change also could reduce future Medicaid costs.

The MHA encourages hospitals to review the proposed policy and submit comments to the MSA by June 21. For more information, contact Vickie Kunz at the MHA.

Tags: MSA, Obstetrics, OB

Posted in: Member News

MHA Updates Delivered to You

Subscribe to the MHA Monday Report weekly newsletter or our podcast, the MiCare Champion Cast, to keep informed about the latest healthcare news and events in Michigan.

MHA Monday Report
Contact us to subscribe

MiCare Champion Cast
iTunes | SoundCloud

Media Inquiries

Contact the MHA at
(517) 703-8601

Read the MHA policy on publication via MHA media.

MHA 100 Year Anniversary

Watch the video »